Boston Scientific Corp. (BSX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Boston Scientific Corp. (BSX)
Company Performance

Current Price

as of Dec 03, 2024

$90.47

P/E Ratio

74.80

Market Cap

$133.28B

Description

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Metrics

Overview

  • HQMarlborough, MA
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerBSX
  • Price$90.47+0.04%

Trading Information

  • Market cap$133.28B
  • Float99.58%
  • Average Daily Volume (1m)5,387,327
  • Average Daily Volume (3m)5,910,149
  • EPS$1.22

Company

  • Revenue$15.91B
  • Rev growth (1yr)19.34%
  • Net income$469.00M
  • Gross margin62.91%
  • EBITDA margin23.31%
  • EBITDA$981.00M
  • EV$133.58B
  • EV/Revenue8.40
  • P/E74.80
  • P/S8.45
  • P/B6.43
Documents